Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
PepGen Inc. - Common Stock
(NQ:
PEPG
)
9.440
+0.370 (+4.08%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about PepGen Inc. - Common Stock
< Previous
1
2
3
4
Next >
PepGen Announces First Patient Dosed in Phase 1 FREEDOM-DM1 Clinical Trial of PGN-EDODM1 for Myotonic Dystrophy Type 1 (DM1)
December 18, 2023
From
PepGen Inc.
Via
GlobeNewswire
PepGen Announces Appointment of Howard Mayer, M.D. to Board of Directors
November 15, 2023
From
PepGen Inc.
Via
GlobeNewswire
PepGen: Q3 Earnings Insights
November 08, 2023
Via
Benzinga
PepGen Reports Third Quarter 2023 Financial Results and Recent Corporate Developments
November 08, 2023
From
PepGen Inc.
Via
GlobeNewswire
The Latest Analyst Ratings for PepGen
June 14, 2023
Via
Benzinga
PepGen: Q1 Earnings Insights
May 11, 2023
Via
Benzinga
Why This PepGen Analyst Is Bullish On The Biotech Stock
December 21, 2022
Via
Benzinga
PepGen Inc. Announces FDA has Lifted the Clinical Hold on its Investigational New Drug Application for FREEDOM-DM1 Phase 1 Study of PGN-EDODM1 for Myotonic Dystrophy Type 1 (DM1)
October 12, 2023
From
PepGen Inc.
Via
GlobeNewswire
PepGen Announces Upcoming Presentations at the 28th Annual Congress of the World Muscle Society and the World Congress of Neurology
September 27, 2023
From
PepGen Inc.
Via
GlobeNewswire
PepGen Inc. Announces Clearance of CTA by Health Canada to Begin the FREEDOM-DM1 Phase 1 Study of PGN-EDODM1 in Patients with Myotonic Dystrophy Type 1
September 06, 2023
The U.S. Food and Drug Administration (FDA) granted Orphan Drug Designation to PGN-EDODM1 for the treatment of Myotonic Dystrophy Type 1 (DM1)
From
PepGen Inc.
Via
GlobeNewswire
PepGen Inc. Presents PGN-EDODM1 Preclinical Data Supporting the Company’s Enhanced Delivery Oligonucleotide Platform and PGN-EDODM1 Program at Two Medical Conferences
September 06, 2023
From
PepGen Inc.
Via
GlobeNewswire
PepGen Announces Presentations at the 2023 Myotonic Dystrophy Foundation Annual Conference, Ottawa Neuromuscular Disease Meeting, and H.C. Wainwright 25th Annual Global Investment Conference
September 01, 2023
From
PepGen Inc.
Via
GlobeNewswire
PepGen Reports Second Quarter 2023 Financial Results and Recent Corporate Developments
August 08, 2023
From
PepGen Inc.
Via
GlobeNewswire
PepGen Inc. Provides Update on Planned Initiation of Phase 1 Study of PGN-EDODM1 in Myotonic Dystrophy Type 1
June 13, 2023
From
PepGen Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's Intraday Session
June 09, 2023
Via
Benzinga
Why American Software Shares Are Trading Lower By Over 20%? Here Are Other Stocks Moving In Friday's Mid-Day Session
June 09, 2023
Gainers Advanced Health Intelligence Ltd. (NASDAQ: AHI) shares jumped 144.5% to $0.7827.
Via
Benzinga
SAIC, HealthEquity And 3 Stocks To Watch Heading Into Monday
June 05, 2023
With U.S. stock futures trading mixed this morning on Monday, some of the stocks that may grab investor focus today are as follows:
Via
Benzinga
PepGen Inc. Announces Clinical Hold in the U.S. on IND Application to Initiate a Phase 1 Study of PGN-EDODM1 for Myotonic Dystrophy Type 1 (DM1)
May 30, 2023
From
PepGen Inc.
Via
GlobeNewswire
PepGen Announces Clearance by Health Canada of CTA for PGN-EDO51 to Begin the Phase 2 Clinical Trial, CONNECT1-EDO51, for the Treatment of Duchenne Muscular Dystrophy
May 18, 2023
From
PepGen Inc.
Via
GlobeNewswire
PepGen Reports First Quarter 2023 Financial Results and Recent Corporate Developments
May 11, 2023
From
PepGen Inc.
Via
GlobeNewswire
Why Jounce Therapeutics Shares Are Trading Higher By 23%? Here Are Other Stocks Moving In Monday's Mid-Day Session
March 27, 2023
Gainers Crown ElectroKinetics Corp. (NASDAQ: CRKN) shares jumped 59.6% to $0.2513. Crown Electrokinetics said it has entered into an agreement with a leading infrastructure solutions provider.
Via
Benzinga
BioNTech, Coinbase Global, Pharming Group And Other Big Stocks Moving Lower On Monday
March 27, 2023
U.S. stocks traded higher, with the Dow Jones gaining around 200 points on Monday. Here are some big stocks recording losses in today’s session.
Via
Benzinga
Why Scholastic Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Friday's Mid-Day Session
March 24, 2023
Gainers Near Intelligence Inc. (NASDAQ: NIR) shares climbed 53.1% to $16.50.
Via
Benzinga
Earnings Scheduled For March 23, 2023
March 23, 2023
Companies Reporting Before The Bell • Cognition Therapeutics (NASDAQ:CGTX) is likely to report earnings for its fourth quarter.
Via
Benzinga
PepGen to Host Fourth Quarter and Full Year 2022 Financial Results Call
March 16, 2023
From
PepGen Inc.
Via
GlobeNewswire
PepGen Announces Upcoming Data Presentations at the 2023 Annual Muscle Dystrophy Association Clinical and Scientific Conference
March 13, 2023
From
PepGen Inc.
Via
GlobeNewswire
PepGen to Participate in the SVB Securities Global Biopharma Conference
February 09, 2023
From
PepGen Inc.
Via
GlobeNewswire
Around $12M Bet On This Technology Stock? Check Out These 3 Stocks Insiders Are Buying
January 20, 2023
Although US stocks closed lower on Thursday, there were a few notable insider trades.
Via
Benzinga
PepGen Announces IND-Enabling Preclinical Data Supporting Progression of PGN-EDODM1 into Clinical Studies
December 07, 2022
From
PepGen Inc.
Via
GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For December 21, 2022
December 21, 2022
Via
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.